BioSpace News Archive

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients battling cancer, announced the grant of options to purchase 1,625 shares of its common stock and the grant of 813 restricted stock units to two new employees.

Rani Therapeutics Holdings, Inc. today announced the appointment of Lisa Rometty to its Board of Directors.

What do you expect to be different about your medical care this year? Expert physicians will respond to this question and other healthcare concerns webinar participants would like to discuss. It’s an opportunity for you to join in and ask medical questions.

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today provided a corporate update and highlighted key milestones anticipated in 2022.

Nonalcoholic fatty liver disease is the most common cause of chronic liver disease worldwide. Conventional diagnosis includes imaging or histological evidence of steatosis in >5% of hepatocytes, and the absence of known causes of chronic liver disease, like alcohol abuse, viral hepatitis, hereditary liver diseases, or long-term usage of steatogenic medications.

Anitoa Systems, a Silicon Valley biotech company has added its SARS-CoV2 Rapid Nucleic Acid Test portfolio to include the detection of Omicron and Delta mutations, which are designated by the World Health Organization (WHO) as COVID-19 variants of concern (VOC).

Vela Diagnostics announced that its Sentosa® SQ HIV-1 Genotyping Assay is covered for reimbursement from The Centers for Medicare and Medicaid starting January 2022.

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that Thomas Schuetz, M.D., Ph.D., Co-founder and Chief Executive Officer, will present a company update at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022.

Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen- and mineral-based medical devices, and Linden Capital Partners portfolio company, announced the appointment of Tony Orsini as Chief Operating Officer.

Christina Brennan, MD, MBA, vice president of clinical research at Northwell Health’s Feinstein Institutes for Medical Research, has been elected by members of the Association of Clinical Research Professionals to serve on its Board of Trustees for a second term.